Product review · Updated September 30, 2026
Paula’s Choice 2% BHA Liquid review: a regional formula and two different footnotes
The liquid toner’s comfort language sits beside an eight-name UK declaration, an empty US ingredient pane and differing study periods.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Paula’s Choice sells a familiar percentage in a less simple product record. Its US Skin Perfecting 2% BHA Liquid Exfoliant is described as a lightweight toner with soothing green tea, while the UK page calls the item an Exfoliating Toner and supplies an identifiable ingredient list. The difference matters when the question concerns the whole liquid and its comfort claims, rather than the salicylic-acid headline alone.
The two manufacturer pages examined on September 30, 2026 support a regional comparison, with several details left unresolved. The US ingredient heading returned no complete declaration. The UK list carries il402v1, but its published study footnotes and pH wording are not identical to the other descriptions. Neither record was checked against a physical bottle, and no underlying study report or independent formula measurement was reviewed.
In this article
The US offer names a liquid toner
The US page identifies Skin Perfecting 2% BHA Liquid Exfoliant and describes a rapidly absorbing liquid exfoliating toner. It also places a green-tea comfort claim beside the acid description. Those statements tell us what the seller intends to communicate about the finished product. They do not establish that every person will find the liquid comfortable. US product description.
A toner description supplies useful context that a percentage cannot. The cream-versus-cleanser guide considers format as part of identity. It does not provide a conversion between this liquid and an acne wash, cream or other product carrying the same number.
Eight ingredient names belong to the UK record
The UK declaration identifies eight ingredients: water, methylpropanediol, butylene glycol, salicylic acid, polysorbate 20, Camellia oleifera leaf extract, sodium hydroxide and tetrasodium EDTA. Its il402v1 identifier offers a concrete reference for the list actually examined. The page separately declares salicylic acid at 2%. UK ingredient record.
This is more informative than a panel naming only acid and green tea. It still describes a particular regional declaration, rather than an analytical result. We cannot reconstruct the finished formula’s behavior from those names or assume that its components have been measured for this review. The green-tea highlight and Camellia ingredient name are parts of the manufacturer’s account. Their presence does not substitute for the missing finished-product report or establish that an isolated ingredient and the complete toner have the same measured result.
The US ingredient pane leaves a real gap
The captured US page contains an Ingredients heading without a populated full list. Its benefit description remains available, so the missing pane does not erase the product’s identity or every statement on the page. It does limit what that record can establish about the complete formula. US page.
Using the UK declaration to fill the US gap would conceal the market boundary. The Dermalogica serum review is another place to examine declaration scope. That link is a reading comparison, not evidence that the two formulas share ingredients, texture or comfort outcomes.
Two pH ranges appear on the UK page
The UK descriptive text reports an optimal pH range of 3.2–3.8. Its ingredient area instead shows 3.2–3.7. The US descriptive text also reports 3.2–3.8. These are published manufacturer values; this review did not measure either liquid. UK description and panel; US description.
The difference should remain visible without inventing its cause. A narrower printed range does not establish a reformulation date or a clinical advantage. There is no examined batch result tying either value to a particular supplied bottle, and the pages do not resolve why their wording differs.
The pore and barrier footnotes have different scopes
For pore appearance and oil control, the US page describes 32 subjects after four weeks; the UK page describes 32 subjects after three weeks. Both pages also attribute a barrier claim to 29 subjects. The UK separately associates smoother lines and brighter-looking skin with 29 subjects after three weeks. US test summaries; UK test summaries.
Those counts do not prove that the pages report one identical experiment. The missing reports prevent checking recruitment, measurements and the relationship between the groups. A pore endpoint is also distinct from a barrier endpoint, even when both appear in the same product story. The UK also attributes a one-week blackhead and whitehead appearance claim to 33 subjects. That is another defined endpoint and cohort, not a reason to pool all the displayed groups into one larger trial or transfer its result into the US pore footnote.
A pad option does not settle the pad formula
The US offer displays full and travel bottles alongside a ten-count pad option. That product-selection interface is evidence that the option appears on the page. It does not supply a separate complete pad declaration or establish that a bottle’s formula and a pad’s delivered preparation are identical. Displayed options.
This distinction helps keep a review from expanding beyond its records. The SkinCeuticals review likewise follows exact format and market identities. Neither comparison supplies an instruction for substituting one format for another or predicts what a reader will feel.
Gentle wording stays an attributed description
Paula’s Choice presents the liquid as gentle and supportive of the skin barrier. Its pages provide defined study summaries and a complete UK list, but leave the US declaration and the differing footnotes unresolved. That is a useful product account with visible boundaries, rather than a demonstrated guarantee against dryness. Manufacturer account.
The mature, dry-skin guide and original format comparison put comfort questions into broader context. Their role is to organize the available evidence. They cannot supply missing results for this toner or turn its regional description into personal suitability advice.
Sources behind this reading
- Paula’s Choice US Skin Perfecting 2% BHA Liquid Exfoliant ↗US manufacturer product record · Checked September 30, 2026
- Paula’s Choice UK Skin Perfecting 2% BHA Exfoliating Toner ↗UK manufacturer product record · Checked September 30, 2026